#1 Clinical Trials Search in Europe

Paroxetine

This article examines the use of paroxetine, an antidepressant medication, in clinical trials for treating various conditions. Paroxetine, also known by brand names like Paxil and Brisdelle, has been studied for its effects on anxiety disorders, menopausal symptoms, social phobia, and more. The trials evaluate the drug’s efficacy, safety, and pharmacokinetics compared to placebos and other treatments.

Table of Contents

What is Paroxetine?

Paroxetine is a medication that belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). It is widely used to treat various mental health conditions and other disorders. Paroxetine is known by several brand names, including Paxil, Paxil CR (controlled release), and Brisdelle[1][2]. In some studies, it is also referred to as paroxetine mesylate or LDMP (Low-Dose Mesylate salt of Paroxetine)[10].

What Conditions Does Paroxetine Treat?

Paroxetine is used to treat several mental health conditions and other disorders, including:

  • Anxiety Disorders: Paroxetine is effective in treating various forms of anxiety, including social anxiety disorder (social phobia)[1][5].
  • Depression: It is commonly prescribed for major depressive disorder[3].
  • Panic Disorder: Paroxetine has shown efficacy in treating panic attacks and panic disorder[4].
  • Vasomotor Symptoms of Menopause: A low-dose formulation of paroxetine (Brisdelle) is used to treat hot flashes and night sweats associated with menopause[10][10].

How Does Paroxetine Work?

Paroxetine works by increasing the levels of a neurotransmitter called serotonin in the brain. Serotonin is a chemical messenger that plays a crucial role in regulating mood, anxiety, and other mental states. By blocking the reuptake (reabsorption) of serotonin, paroxetine allows more serotonin to remain available in the brain, which can help improve mood and reduce anxiety symptoms[4].

Dosage Forms and Strengths

Paroxetine is available in several forms and strengths:

  • Immediate-release tablets: Usually available in strengths of 20 mg, 30 mg, and 40 mg[1].
  • Controlled-release tablets (Paxil CR): Available in 37.5 mg strength[3].
  • Low-dose capsules (Brisdelle): Available as 7.5 mg capsules for treating menopausal symptoms[10][10].

The dosage and form prescribed will depend on the condition being treated and individual patient factors. It’s important to take paroxetine exactly as prescribed by your healthcare provider.

Effectiveness of Paroxetine

Clinical trials have demonstrated the effectiveness of paroxetine in treating various conditions:

  • Anxiety and Depression: Studies have shown that paroxetine can significantly improve symptoms of anxiety and depression compared to placebo[5].
  • Panic Disorder: Research indicates that paroxetine can reduce the frequency and severity of panic attacks[4].
  • Menopausal Symptoms: Low-dose paroxetine (Brisdelle) has been found to reduce the frequency and severity of hot flashes in postmenopausal women[10][10].

The effectiveness of paroxetine may vary from person to person, and it may take several weeks to experience the full benefits of the medication.

Potential Side Effects

Like all medications, paroxetine can cause side effects. Common side effects may include:

  • Nausea
  • Drowsiness
  • Dry mouth
  • Insomnia
  • Sexual dysfunction
  • Changes in appetite or weight

Most side effects are mild and tend to improve over time. However, if you experience any severe or persistent side effects, it’s important to contact your healthcare provider[1][10].

Use in Special Populations

Paroxetine should be used with caution in certain populations:

  • Pregnant Women: The use of paroxetine during pregnancy should be carefully considered due to potential risks to the fetus.
  • Elderly Patients: Lower doses may be recommended for older adults to reduce the risk of side effects.
  • Patients with Liver or Kidney Disease: Dose adjustments may be necessary for individuals with impaired liver or kidney function.

Always inform your healthcare provider about your complete medical history and any other medications you are taking before starting paroxetine[10][10].

Drug Interactions

Paroxetine can interact with various medications and substances. Some important interactions to be aware of include:

  • Other antidepressants, particularly monoamine oxidase inhibitors (MAOIs)
  • Certain pain medications
  • Blood thinners
  • Some migraine medications
  • Alcohol

It’s crucial to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions[1][10].

Aspect Details
Conditions Studied Anxiety disorders, menopausal symptoms, social phobia, panic disorder, depression
Dosage Range 7.5 mg to 40 mg, depending on condition and formulation
Study Durations Single dose to 24 weeks or longer
Outcome Measures Symptom scales, patient-reported outcomes, physiological measurements
Safety Assessments Adverse events, vital signs, sexual function, mood changes, weight impacts
Comparison Groups Placebos, other antidepressants, cognitive therapy
Special Populations Menopausal women, patients with cardiovascular disease

FAQ

  • What conditions was paroxetine studied for in these clinical trials? Paroxetine was studied for several conditions including anxiety disorders, menopausal symptoms like hot flashes, social phobia, panic disorder, and depression. It was also evaluated for potential cardiovascular benefits.
  • How was paroxetine's effectiveness measured in the trials? Effectiveness was measured through various means including symptom scales, patient-reported outcomes, physiological measurements like hot flash frequency, and comparisons to placebos or other treatments. Bioequivalence studies also examined how different formulations were absorbed by the body.
  • What were some of the side effects or safety concerns evaluated? The trials looked at adverse events, changes in vital signs, effects on sexual function, changes in mood and anxiety levels, and impacts on body weight. Long-term safety and tolerability were also assessed in some studies.
  • What dosages of paroxetine were typically used in the trials? Dosages varied depending on the condition and formulation being studied. They ranged from low doses like 7.5 mg for menopausal symptoms up to 40 mg for anxiety disorders. Some trials compared multiple dose levels.
  • How long did the clinical trials for paroxetine typically last? The duration varied widely, from single-dose pharmacokinetic studies to long-term trials lasting 24 weeks or more. Many efficacy trials lasted 12 weeks, with some including longer follow-up periods to assess ongoing benefits and safety.

Ongoing Clinical Trials on Paroxetine

  • Safe Discontinuation of Antidepressants in Patients with Remitted Depression: Amitriptyline, Fluoxetine, Paroxetine, and Drug Combination Study

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Poland

  • Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland Spain

Glossary

  • Bioequivalence: A comparison of how two drug formulations are absorbed by the body to determine if they have the same effect. This is often used to compare generic versions to brand-name drugs.
  • Pharmacokinetics: The study of how a drug moves through the body, including how it's absorbed, distributed, metabolized and eliminated. This helps determine proper dosing and timing of medication.
  • Placebo: An inactive substance that looks like the drug being tested but has no medical effect. It's used as a control in clinical trials to compare against the actual drug.
  • Vasomotor symptoms: Physical symptoms like hot flashes and night sweats that are common during menopause due to hormonal changes affecting blood vessel dilation.
  • COAT-platelets: A type of activated platelet in the blood that may play a role in blood clotting and heart attacks. Some studies looked at paroxetine's effect on these.
  • Cognitive therapy: A type of psychological treatment that focuses on changing negative thought patterns. Some trials compared paroxetine to this therapy for treating phobias.
  • Bioavailability: The amount of a drug that enters the bloodstream and is available to have an active effect in the body after it's taken.

References

  1. https://clinicaltrials.gov/study/NCT04311463
  2. https://clinicaltrials.gov/study/NCT01829919
  3. https://clinicaltrials.gov/study/NCT00749359
  4. https://clinicaltrials.gov/study/NCT00767754
  5. https://clinicaltrials.gov/study/NCT00184106
  6. https://clinicaltrials.gov/study/NCT00841659
  7. https://clinicaltrials.gov/study/NCT00841698
  8. https://clinicaltrials.gov/study/NCT00229528
  9. https://clinicaltrials.gov/study/NCT01101841
  10. https://clinicaltrials.gov/study/NCT01361308